Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Stockholders Deficit - Stock Compensation Activity (Details)

v3.24.1.u1
Note 7 - Stockholders Deficit - Stock Compensation Activity (Details) - USD ($)
 3 Months Ended
Mar. 31, 2024
Dec. 31, 2023
Sep. 30, 2023
Outstanding, Option Shares Outstanding (in shares) 100,300 102,125  
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 38 $ 38  
Outstanding, Weighted Average Remaining Contractual Term (Year) 5 years 4 years 5 years 6 months 29 days
Outstanding, Aggregate Intrinsic Value $ 11,000 $ 0  
Awarded, Option Shares Outstanding (in shares) 0 0  
Awarded, Weighted Average Exercise Price (in dollars per share) $ 0 $ 0  
Forfeited/Cancelled, Option Shares Outstanding (in shares) (12,025) (1,825)  
Forfeited/Cancelled, Weighted Average Exercise Price (in dollars per share) $ (58) $ (67)  
Outstanding, Option Shares Outstanding (in shares) 88,275 100,300 102,125
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 35 $ 38 $ 38
Outstanding, Aggregate Intrinsic Value $ 0 $ 11,000 $ 0
Vested, Option Shares Outstanding (in shares) 74,769    
Vested, Weighted Average Exercise Price (in dollars per share) $ 39    
Vested, Weighted Average Remaining Contractual Term (Year) 3 years 6 months    
Vested, Aggregate Intrinsic Value $ 0    
Vested and Expected to Vest, Option Shares Outstanding (in shares) 88,275    
Vested and Expected to Vest, Weighted Average Exercise Price (in dollars per share) $ 35    
Vested and Expected to Vest, Weighted Average Remaining Contractual Term (Year) 5 years    
Vested and Expected to Vest, Aggregate Intrinsic Value $ 0